2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 129 filers reported holding 2SEVENTY BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,874,320 | -52.8% | 1,243,449 | +21.8% | 0.01% | -50.0% |
| Q2 2023 | $10,332,044 | -0.5% | 1,020,953 | +0.3% | 0.01% | 0.0% |
| Q1 2023 | $10,383,336 | +10.1% | 1,017,974 | +1.1% | 0.01% | 0.0% |
| Q4 2022 | $9,433,182 | -35.5% | 1,006,743 | +0.1% | 0.01% | -37.5% |
| Q3 2022 | $14,633,000 | +10.2% | 1,005,750 | -0.1% | 0.02% | +14.3% |
| Q2 2022 | $13,284,000 | -22.5% | 1,006,362 | +0.2% | 0.01% | -6.7% |
| Q1 2022 | $17,134,000 | -19.8% | 1,004,372 | +20.5% | 0.02% | +36.4% |
| Q4 2021 | $21,362,000 | – | 833,484 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |